SARS-CoV-2 vaccine does not increase new-onset seizure risk
Apr 30, 2024
The findings compared with placebo at 28-day and 43-day follow-up.
Positive link identified between SARS-CoV-2 and Guillain-Barré
Oct 18, 2023
Odds ratio of 6.30 for Guillain-Barré syndrome association with SARS-CoV-2 infection and 0.41 for COVID-19 vaccine administration.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
CDC may recommend COVID boosters for some this spring
Feb 16, 2024
The panel is expected to focus on the safety of high-risk Americans, including people 65 and older and anyone with a weakened immune system.
Health officials recommend spring COVID-19 booster for older adults
Feb 29, 2024
A second booster is appropriate as long as at least four months have passed since a person’s last COVID-19 shot.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.